Search research articles
Contact Us
Filters
Showing results (11-20 of 70) with videos related to
Page
of 7
Sort By:
Current Protein & Peptide Science
|
October 9, 2002
Mif1: a missing link between the unfolded protein response pathway and ER-associated protein degradation?
T van Laar, A J van der Eb, C Terleth
Spinal Cord
|
April 1, 2009
The incidence and management of tolerance in intrathecal baclofen therapy
H W Heetla, M J Staal, C Kliphuis, et al.
BMC Neurology
|
May 1, 2024
Study protocol of the GRoningen early-PD Ambroxol treatment (GREAT) trial: a randomized, double-blind, placebo-controlled, single center trial with ambroxol in Parkinson patients with a GBA mutation
O Siemeling, S Slingerland, S van der Zee, et al.
Clinical Neuropharmacology
|
February 1, 1994
Pharmacokinetics of apomorphine in Parkinson's disease: plasma and cerebrospinal fluid levels in relation to motor responses
D J Hofstee, C Neef, T van Laar, et al.
Archives of Neurology
|
May 1, 1992
Intranasal apomorphine in parkinsonian on-off fluctuations
T van Laar, E N Jansen, A W Essink, et al.
Psychiatry Research
|
August 26, 2019
Visual hallucinations in psychosis
M M van Ommen, T van Laar, F W Cornelissen, et al.
Molecular Carcinogenesis
|
June 29, 2001
Induction of the SAPK activator MIG-6 by the alkylating agent methyl methanesulfonate
T van Laar, T Schouten, A J van der Eb, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
July 1, 1995
Pharmacokinetics and clinical efficacy of rectal apomorphine in patients with Parkinson's disease: a study of five different suppositories
T van Laar, E N Jansen, C Neef, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
November 1, 1996
A new sublingual formulation of apomorphine in the treatment of patients with Parkinson's disease
T van Laar, C Neef, M Danhof, et al.
Clinical Neuropharmacology
|
October 23, 1997
Movement characteristics in Parkinson's disease: determination of dopaminergic responsiveness and threshold
J J van Hilten, E A Wagemans, S F Ghafoerkhan, et al.
Page
of 7
Search research articles
Search
Showing results (11-20 of 70) with videos related to
Sort By:
Page
of 7
Current Protein & Peptide Science
|
October 9, 2002
Mif1: a missing link between the unfolded protein response pathway and ER-associated protein degradation?
T van Laar, A J van der Eb, C Terleth
Spinal Cord
|
April 1, 2009
The incidence and management of tolerance in intrathecal baclofen therapy
H W Heetla, M J Staal, C Kliphuis, et al.
BMC Neurology
|
May 1, 2024
Study protocol of the GRoningen early-PD Ambroxol treatment (GREAT) trial: a randomized, double-blind, placebo-controlled, single center trial with ambroxol in Parkinson patients with a GBA mutation
O Siemeling, S Slingerland, S van der Zee, et al.
Clinical Neuropharmacology
|
February 1, 1994
Pharmacokinetics of apomorphine in Parkinson's disease: plasma and cerebrospinal fluid levels in relation to motor responses
D J Hofstee, C Neef, T van Laar, et al.
Archives of Neurology
|
May 1, 1992
Intranasal apomorphine in parkinsonian on-off fluctuations
T van Laar, E N Jansen, A W Essink, et al.
Psychiatry Research
|
August 26, 2019
Visual hallucinations in psychosis
M M van Ommen, T van Laar, F W Cornelissen, et al.
Molecular Carcinogenesis
|
June 29, 2001
Induction of the SAPK activator MIG-6 by the alkylating agent methyl methanesulfonate
T van Laar, T Schouten, A J van der Eb, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
July 1, 1995
Pharmacokinetics and clinical efficacy of rectal apomorphine in patients with Parkinson's disease: a study of five different suppositories
T van Laar, E N Jansen, C Neef, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
November 1, 1996
A new sublingual formulation of apomorphine in the treatment of patients with Parkinson's disease
T van Laar, C Neef, M Danhof, et al.
Clinical Neuropharmacology
|
October 23, 1997
Movement characteristics in Parkinson's disease: determination of dopaminergic responsiveness and threshold
J J van Hilten, E A Wagemans, S F Ghafoerkhan, et al.
Page
of 7